[Ip-health] New Tufts study on R&D costs

Patrick Durisch durisch at ladb.ch
Sun Nov 16 23:01:00 PST 2014

1.97 billion



Déclaration de Berne - Berne Declaration
Patrick Durisch
Responsable Programme Santé - Health Programme Coordinator
Av. Charles-Dickens 4, CH - 1006 Lausanne
Tel. direct: +41 21 620 03 06
Fax: +41 21 620 03 00
Email: durisch at ladb.ch<mailto:durisch at ladb.ch>
Web: www.ladb.ch<http://www.ladb.ch/>

WANTED en Suisse : une autorité de surveillance pour lutter contre la malédiction des ressources !
En savoir plus : ladb.ch/rohma<http://www.ladb.ch/rohma>

-----Message d'origine-----
De : Ip-health [mailto:ip-health-bounces at lists.keionline.org] De la part de Jamie Love
Envoyé : vendredi 14 novembre 2014 18:35
À : Ip-health
Objet : [Ip-health] New Tufts study on R&D costs

Next week, a new version of the Tufts study on R&D costs will be released.

KEI will give $50 to the person who comes the closed in predicting the new figure for the cost of R&D for the lead indication of a new chemical entity.

An abstract of the earlier 2003 study,"The price of innovation: new estimates of drug development costs" is available here:


The 2003 study put the number at $802 million (not $800 million, but $802 million), in 2000 dollars.

As I said, $50 for the closest estimate, published on IP-Health, before the new number is announced (or leaked).



James Love.  Knowledge Ecology International http://www.keionline.org/donate.html

KEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile:

+41.76.413.6584, twitter.com/jamie_love


Ip-health mailing list

Ip-health at lists.keionline.org<mailto:Ip-health at lists.keionline.org>


More information about the Ip-health mailing list